Home » Watson Signs Exclusive Agreement to Distribute Authorized Generic Concerta
Watson Signs Exclusive Agreement to Distribute Authorized Generic Concerta
Watson Pharmaceuticals, Inc. Tuesday announced that its subsidiary, Watson Laboratories, Inc., has entered into an exclusive agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. to market the authorized generic version of Concerta (methylphenidate hydrochloride extended-release tablets).
Forbes
Forbes
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May